Vita 34 AG
A cell bank storing umbilical cord stem cells as biological insurance for families' future health.
V3V | F
Overview
Corporate Details
- ISIN(s):
- DE000A0BL849
- LEI:
- 529900OEWA4GSZEZ4P40
- Country:
- Germany
- Address:
- Perlickstr. 5, 04103 Leipzig
- Website:
- https://www.vita34.de/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Vita 34 AG is a leading European biotechnology company and full-service cell bank specializing in cryopreservation. The company's core services include the collection, processing, and long-term storage of stem cells derived from umbilical cord blood and tissue. These potent hematopoietic and mesenchymal stem cells are preserved for potential future use in regenerative medicine and the treatment of numerous diseases. Established in 1997 as Europe's first private cord blood bank, Vita 34 has consistently been a pioneer in the field. Following a business combination with Polski Bank Komórek Macierzystych S.A., the company has expanded its European leadership and now operates as part of the FamiCord Group, providing families with a form of biological insurance for future health.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Vita 34 AG and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-16 18:53 |
M&A Activity
FamiCord AG: Polski Bank Komorek Macierzystych sp. z o. o. is to acquire 100 % …
|
English | 6.0 KB | |
| 2025-08-27 07:00 |
Earnings Release
FamiCord AG significantly increases revenue and earnings in the first half of 2…
|
English | 19.8 KB | |
| 2025-08-27 00:00 |
Interim Report
Half-yearly financial report 2025
|
English | 358.1 KB | |
| 2025-08-20 13:23 |
Report Publication Announcement
|
English | 3.9 KB | |
| 2025-06-10 00:00 |
Annual / Quarterly Financial Statement
Jahresabschluss zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
|
German | 348.2 KB | |
| 2025-05-29 16:19 |
M&A Activity
FamiCord AG acquires majority stake in Narodni Centrum Pupecnikove Krve and Rod…
|
English | 6.6 KB | |
| 2025-05-28 07:00 |
Earnings Release
FamiCord AG starts 2025 financial year with accelerated growth and increases pr…
|
English | 16.6 KB | |
| 2025-05-28 00:00 |
Quarterly Report
Q1 statement / Q1 financial report 2025
|
English | 675.0 KB | |
| 2025-05-19 00:00 |
Annual Report
Konzernabschluss zum Geschäftsjahr vom 01.01.2024 bis zum 31.12.2024
|
German | 1.6 MB | |
| 2025-05-15 15:05 |
Pre-Annual General Meeting Information
FamiCord AG: Bekanntmachung der Einberufung zur Hauptversammlung am 25.06.2025 …
|
German | 88.4 KB | |
| 2025-04-30 14:09 |
Earnings Release
FamiCord AG continues growth course in 2024 after strong year-end business and …
|
English | 18.6 KB | |
| 2025-04-30 00:00 |
Annual Report
Annual financial report 2024
|
English | 6.9 MB | |
| 2025-04-23 16:18 |
Report Publication Announcement
|
English | 4.4 KB | |
| 2025-04-23 00:00 |
Report Publication Announcement
Hinweis auf Jahresfinanzbericht vom 01.01.2024 bis zum 31.12.2024
|
German | 5.7 KB | |
| 2025-04-23 00:00 |
Report Publication Announcement
Hinweis auf Konzernabschluss vom 01.01.2024 bis zum 31.12.2024
|
German | 5.7 KB |
Automate Your Workflow. Get a real-time feed of all Vita 34 AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Vita 34 AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2023-12-11 | AOC Health GmbH | Close relation | Other | None | 6,572,680.40 EUR |
| 2023-12-11 | Baran, Jakub Julian | Other | Buy | None | 99,998.80 EUR |
| 2022-09-28 | Dr. Granderath, Rat und Vermögen GmbH | Close relation | Buy | None | 21,557.28 EUR |
| 2022-06-02 | Dr. Granderath, Rat und Vermögen GmbH | Close relation | Buy | None | 33,000.00 EUR |
| 2022-06-02 | Schweppe, Thomas | Supervisory board | Other | None | N/A |
| 2021-11-18 | Lorenzen, Hans-Jochen | Supervisory board | Sell | None | 180,625.00 EUR |
| 2021-11-10 | Project Mill Gesellschaft für interdisziplinären Know-how-Transfer GmbH | Close relation | Other | None | 36,146.25 EUR |
| 2021-11-09 | Zeitfracht GmbH & Co. KGaA | Close relation | Sell | None | 35,525.00 EUR |
| 2021-11-09 | von Blücher, Dietmar | Board | Buy | None | 28,820.00 EUR |
| 2021-11-09 | von Blücher, Dietmar | Board | Buy | None | 14,400.00 EUR |
